Check out your Company Bowl for anonymous work chats.
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston! New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticals Site will employ highly flexible, automated production lines plus state-of-the-art services and digitalization technologies Multi-product facility to focus on commercial production of complex molecules for U.S.-based clients
